Cosmos Health | 8-K/A: Current report (Amendment)
May 4 00:55
Cosmos Health | 8-K/A: Current report (Amendment)
May 2 18:08
Cosmos Health | 8-K: Current report
Apr 27 04:37
Cosmos Health | 8-K: Entered Into A Rights Agreement
Apr 26 05:27
Cosmos Health | 8-K: Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
Apr 20 05:05
Cosmos Health | NT 10-K: Others
Apr 3 04:37
Cosmos Health | 8-K: Cosmos Health Receives a Non-Compliance Letter from Nasdaq and Company Defines Policies and Procedures for Related Party Transactions
Mar 23 04:30
Cosmos Health | S-3: Registration statement for specified transactions by certain issuers
Jan 30 06:20
Cosmos Health | 8-K: Cosmos Health Announces Acquisition of Licenses and Rights to 10 Generic Drugs for €3.2 Million
Jan 22 13:00
Cosmos Health | 8-K/A: Cosmos Health Set for Substantial Growth from Acquisitions Completed in 2023 and Entered into a Warrant Exchange Agreement (Amendment)
Dec 29, 2023 13:00
Cosmos Health | 8-K: Cosmos Health Set for Substantial Growth from Acquisitions Completed in 2023 and Entered into a Warrant Exchange Agreement
Dec 29, 2023 13:00
Cosmos Health | 8-K: Cosmos Health Board of Directors Adopted a Executive Compensation Clawback Policy
Nov 29, 2023 05:05
Cosmos Health | 8-K: Cosmos Health Reports Q3 2023 Results
Nov 22, 2023 22:30
Cosmos Health | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Nov 15, 2023 05:00
Cosmos Health | 8-K: CEO Issues Letter to Shareholders
Oct 11, 2023 04:05
Cosmos Health | 8-K: Current report
Oct 4, 2023 04:05
Cosmos Health | 8-K: Pavlos Ignatiades Chief Communications Officer Resignation and Poll Results of 2023 Annual Meeting of Shareholders
Sep 23, 2023 04:05
Cosmos Health | 8-K: Cosmos Health Announced Its Fiscal 2026 EBITDA Guidance
Sep 15, 2023 05:17
Cosmos Health | DEF 14A: Definitive information statements
Sep 6, 2023 00:25
Cosmos Health | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Aug 24, 2023 05:12
No Data
No Data